Recombinant Human Interferon Alpha 2b Prevents and Reverses Experimental Pulmonary Hypertension-Reference-Cited by-同舟云学术

Recombinant Human Interferon Alpha 2b Prevents and Reverses Experimental Pulmonary Hypertension

Published:2014-05-16 Issue:5 Volume:9 Page:e96720
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Bauer Eileen M.,Zheng Han,Lotze Michael T.,Bauer Philip M.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference52 articles.

1. Cellular and molecular mechanisms in the pathogenesis of severe pulmonary hypertension;NF Voelkel;Eur Respir J,1995

2. Hypoxia-induced pulmonary vascular remodeling: a model for what human disease?;NF Voelkel;J Clin Invest,2000

3. Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension;RM Tuder;Am J Pathol,1994

4. Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension;SD Lee;J Clin Invest,1998

5. Hyperproliferative apoptosis-resistant endothelial cells in idiopathic pulmonary arterial hypertension;FA Masri;Am J Physiol Lung Cell Mol Physiol,2007

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ultrasound Neuromodulation of an Anti-Inflammatory Pathway at the Spleen Improves Experimental Pulmonary Hypertension;Circulation Research;2024-06-21

2. Non–Interferon-Dependent Role of STING Signaling in Pulmonary Hypertension;Arteriosclerosis, Thrombosis, and Vascular Biology;2024-01

3. Ultrasound neuromodulation of an anti-inflammatory pathway at the spleen produces sustained improvement of experimental pulmonary hypertension;2023-03-28

4. Cell dichotomous role of STING in pulmonary hypertension;2022-11-29

5. Epigenetic Regulation of Endothelial Dysfunction and Inflammation in Pulmonary Arterial Hypertension;International Journal of Molecular Sciences;2021-11-09